Skip directly to page options Skip directly to A-Z link
Volume 18, Number 12—December 2012
CME ACTIVITY - Research

Farm Animal Contact as Risk Factor for Transmission of Bovine-associated Salmonella Subtypes

Kevin J. CummingsComments to Author , Lorin D. Warnick, Margaret A. Davis, Kaye Eckmann, Yrjö T. Gröhn, Karin Hoelzer, Kathryn MacDonald, Timothy P. Root, Julie D. Siler, Suzanne M. McGuire, Martin Wiedmann, Emily M. Wright, Shelley M. Zansky, and Thomas E. Besser
Author affiliations: Author affiliations: Texas A&M University, College Station, Texas, USA (K.J. Cummings); Cornell University, Ithaca, New York, USA (K.J. Cummings, L.D. Warnick, Y.T. Gröhn, K. Hoelzer, J.D. Siler, M. Wiedmann, E.M. Wright); Washington State University, Pullman, Washington, USA (M.A. Davis, T.E. Besser); Washington State Department of Health, Olympia, Washington, USA (K. Eckmann, K. MacDonald); New York State Department of Health, Albany, New York, USA (T.P. Root, S.M. McGuire, S.M. Zansky)

Main Article

Table 1

Distribution of Salmonella serovars among 835 patients, New York, USA, March 1, 2008–March 1, 2010

Serovar
No. (%)
Case-patients, n = 40

Typhimurium

 27 (67.5)

Dublin

 7 (17.5)

Newport

 5 (12.5)

Infantis

 1 (2.5)
Control-patients, n = 356

Enteritidis

 36 (10.1)

Typhimurium

 36 (10.1)

Heidelberg

 32 (9.0)

Newport

 21 (5.9)

Braenderup

 16 (4.5)

Javiana

 14 (3.9)

Saintpaul

 13 (3.7)

Hadar

 12 (3.4)

B,5:i:–

 11 (3.1)

Muenchen

 10 (2.8)

Agona

 8 (2.2)

Berta

 8 (2.2)

Paratyphi B var. L-tartrate+

 8 (2.2)

B,5:b:–

 7 (2.0)

Poona

 7 (2.0)

Stanley

 7 (2.0)

Hartford

 6 (1.7)

Miami

 6 (1.7)

Montevideo

 6 (1.7)

Schwarzengrund

 5 (1.4)

Bovismorbificans

 4 (1.1)

Derby

 4 (1.1)

Ealing

 4 (1.1)

Manhattan

 4 (1.1)

Mississippi

 4 (1.1)

Other serovars

 67 (18.8)
Excluded patients, n = 439

Enteritidis

 195 (44.4)

Typhimurium

 99 (22.6)

Thompson

 22 (5.0)

Oranienburg

 18 (4.1)

Newport

 14 (3.2)

Montevideo

 8 (1.8)

Infantis

 7 (1.6)

Tennessee

 7 (1.6)

Panama

 6 (1.4)

Other serovars

 46 (10.5)

Not typed

 17 (3.9)

Main Article

Page created: November 20, 2012
Page updated: November 20, 2012
Page reviewed: November 20, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external